TGA The Therapeutic Goods Administration (TGA), part of the Department of Health, has issued two infringement notices totalling $26,640 to Perth-based company V P & Associates Pty Ltd (V P & Associates), for alleged unlawful advertising of a medical device marketed for the prevention of “SARS-CoV-2 Human Coronavirus”. V P & Associates allegedly advertised, on the company’s website, a plant-based nasal and oral solution called Liquim that claimed it has 99.9% effectiveness against SARS-CoV-2 Human Coronavirus. The product had not been approved for inclusion in the Australian Register of Therapeutic Goods (ARTG) as a preventative for SARS-CoV-2 Human Coronavirus. The Therapeutic Goods Act 1989 (the Act), prohibits advertising to the public for therapeutic goods that are not entered in the ARTG (unless a specific exemption, approval or authority applies). The inclusion of products in the ARTG through the regulatory approval process is an important safeguard to ensure the safety and satisfactory performance of medical devices supplied in Australia.